Transdermal Drug Delivery System Market Global Trends, Size, Segments and Growth till 2027 - PowerPoint PPT Presentation

About This Presentation
Title:

Transdermal Drug Delivery System Market Global Trends, Size, Segments and Growth till 2027

Description:

The transdermal drug delivery system market was valued at US$ 6,063.85 million in 2019 and is projected to reach US$ 8,415.04 million 2027; it is expected to grow at a CAGR of 4.3% from 2020 to 2027. – PowerPoint PPT presentation

Number of Views:6

less

Transcript and Presenter's Notes

Title: Transdermal Drug Delivery System Market Global Trends, Size, Segments and Growth till 2027


1
Transdermal Drug Delivery System Market Sales
Revenue, Growth Factors, Future Trends 2027
  • Published Date May 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com
  • Transdermal Drug Delivery System Market Forecast
    to 2027 - COVID-19 Impact and Global Analysis by
    Type (Transdermal Patches and Transdermal
    Semisolids) Application (Cardiovascular
    Diseases, Central Nervous System Disorders, Pain
    Management, Hormonal Applications and Others)
    End User (Hospitals Clinics, Home Care Settings
    and Others) and Geography

3
Transdermal Drug Delivery System Market Overview
Email sales_at_theinsightpartners.com
  • The Transdermal Drug Delivery System Market was
    valued at US 6,063.85 million in 2019 and is
    projected to reach US 8,415.04 million 2027 it
    is expected to grow at a CAGR of 4.3 from 2020
    to 2027.
  • The report highlights trends prevailing in the
    global transdermal drug delivery system market
    and the factors driving market along with those
    that act as hindrances. Based on the type, the
    global transdermal drug delivery system market is
    segmented into transdermal patches and
    transdermal semisolids. The transdermal patch
    segment is further sub segmented into
    drug-in-adhesive patches, matrix patches,
    reservoir membrane patches, and micro needle
    patches. The transdermal semisolids segment is
    further sub segmented into gels, ointments, and
    sprays. 

4
Key Segment Market
Email sales_at_theinsightpartners.com
  • Segment By Type-
  • By Product (Transdermal Patches, Transdermal
    Semisolids and Others)
  • Application (Cardiovascular Diseases, Central
    Nervous System Disorders, Pain Management,
    Hormonal Applications)
  • End-User (Hospitals and Clinics, Home Care
    Settings, Other End Users)

Download Sample
5
Transdermal Drug Delivery System Market Value
Email sales_at_theinsightpartners.com
  • CAGR of 4.3
  • (2020 - 2027)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com
  • Novartis Ag
  • Johnson Johnson Services, Inc.
  • Glaxosmithkline Plc.
  • Bayer Ag
  • Mylan N.V.
  • Boehringer Ingelheim International Gmbh
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Luye Pharma Group
  • Purdue Pharma L.P.
  • Lavipharm

Download Sample
7
By Geography
Email sales_at_theinsightpartners.com
  • North America (the US, Canada, and Mexico)
  • Europe (the UK, Germany, France, Italy, Spain,
    and the Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia,
    South Korea, and the Rest of Asia Pacific)
  • Middle East Africa (the UAE, Saudi Arabia,
    South Africa, and the Rest of Middle East
    Africa)
  • South Central America (Brazil, Argentina, and
    the Rest of South Central America).

8
THANKYOU!
  • Phone  1-646-491-9876
  • E-Mail sales_at_theinsightpartners.com
Write a Comment
User Comments (0)
About PowerShow.com